Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 24/4/2019
SIETES contiene 92718 citas

 
 
 1 a 20 de 263 siguiente >>
Presentar resultados
Seleccionar todas
1.Enlace a cita original Cita con resumen
Rodríguez-Martín S, Martín-Merino E, Lerma V, Rodríguez-Miguel A, González O. Incidence of Stevens-Johnson syndrome/toxic epidermal necrolysis among new users of different individual drugs in a European population: a case-population study. Eur J Clin Pharmacol 2019;75:febrero. [Ref.ID 103013]
2.Enlace a cita original Cita con resumen
Muanda FT, Sheehy O, Bérard A. Use of trimethoprim–sulfamethoxazole during pregnancy and risk of spontaneous abortion: a nested case control study. Br J Clin Pharmacol 2018;84:junio. [Ref.ID 102803]
3. Cita con resumen
Chan WY, Clark AB, Wilson AM, Loke YK, on behalf of the TIPAC investigators. The effect of co-trimoxazole on serum potassium concentration: safety evaluation of a randomized controlled trial. Br J Clin Pharmacol 2017;83:agosto. [Ref.ID 101544]
4.Enlace a cita original Cita con resumen
González R, Sevene E, Jagoe G, Slutsker L, Menéndez C. A public health paradox: the women most vulnerable to malaria are the least protected. PLOS Medicine 2016:3 de mayo. [Ref.ID 100350]
5.Enlace a cita original Cita con resumen
Talan DA, Mower WR, Krishnadasan A, Abrahamian FM, Lovecchio F, Karras DJ, Steele MT, Rothman RE, Hoagland R, Moran GJ. Trimethoprim–sulfamethoxazole versus placebo for uncomplicated skin abscess. N Engl J Med 2016;374:3 de marzo. [Ref.ID 100027]
6. Cita con resumen
Antoniou T, Hollands S, Macdonald EM, Gomes T, Mamdani MM, Juurlink DN, Canadian Drug Safety and Effectiveness Research Network.. Trimethoprim-sulfamethoxazole and risk of sudden death among patients taking spironolactone. Can Med Assoc J 2015;187:E138-143. [Ref.ID 98851]
7.Tiene citas relacionadas Cita con resumen
Fralick M, Macdonald EM, Gomes T, Antoniou T, Hollands S, Mamdani MM, Juurlink DN, for the Canadian Drug Safety and Effectiveness Research Network (CDSERN). Co-trimoxazole and sudden death in patients receiving inhibitors of renin-angiotensin system: population based study. BMJ 2014;349:g6196. [Ref.ID 98361]
8.Tiene citas relacionadas
Etminan M, Brophy JM. Antibiotics and sudden death in adults taking renin-angiotensin system blockers. BMJ 2014;349:g6242. [Ref.ID 98356]
9.Tiene citas relacionadas Cita con resumen
Hay D, Hill M, Littlewood T. Neutropenia in primary care. BMJ 2014;349:g5340. [Ref.ID 98347]
10. Cita con resumen
11.
Anónimo. Drugs for urinary tract infections. JAMA 2014;311:855-6. [Ref.ID 97160]
12. Cita con resumen
Anónimo. Drug-induced liver injury. Australian Prescriber 2013;36:168-9. [Ref.ID 96320]
13. Cita con resumen
Anónimo. Syndrome d'hypersensibilité multiorganique d'origine médicamenteuse. Prescrire 2012;32:832. [Ref.ID 93980]
14. Cita con resumen
Garbe E, Andersohn F, Bronder E, Salama A, Klimpel A, Thomae M, Schrezenmeier H, Hildebrandt M, Späth-Schwalbe E, Grüneisen A, Meyer O, Kurtal H. Drug-induced immune thrombocytopaenia: results from the Berlin Case-Control Surveillance Study. Eur J Clin Pharmacol 2012;68:821-32. [Ref.ID 92827]
15. Cita con resumen
16. Cita con resumen
Reuben A, Koch DG, Lee WM, Acute Liver Failure Study Group. Drug-induced acute liver failure: results of a U.S. multicenter, prospective study. Hepatology 2010;52:2065-76. [Ref.ID 89970]
17. Cita con resumen
Youngster I, Arcavi L, Schechmaster R, Akayzen Y, Popliski H, Shimonov J, Beig S, Berkovitch M. Medications and glucose-6-phosphate dehydrogenase deficiency: an evidence-based review. Drug Saf 2010;33:713-26. [Ref.ID 89267]
18.
Blomberg J, Lagergren P, Martin LA, Mattsson F, Lagergren J. Novel approach to antibiotic prophylaxis in percutaneous endoscopic gastrostomy (PEG): randomised controlled trial. BMJ 2010;341:81. [Ref.ID 88871]
19. Cita con resumen
Kurien M, Sanders DS. Antibiotic prophylaxis after percutaneous endoscopic gastrostomy. BMJ 2010;341:55-6. [Ref.ID 88867]
Seleccionar todas
 
 1 a 20 de 263 siguiente >>